Buy or sell Ginger stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Ginger Stock
On-Demand behavioral healthcare
About Ginger Stock
Ginger is proven to help people get better by providing on-demand coaching, teletherapy, telepsychiatry and guided self-care - right through a smartphone. Within seconds, members have access to a behavioral health coach - 24/7, 365 days a year. Within 48 hours, members can also get a virtual appointment with our therapists and psychiatrists. Ginger is the only behavioral health provider that continuously uses AI & machine learning to improve both access to and quality of care for anyone managing symptoms of stress, anxiety, depression or more complex challenges. Our AI technology has been recognized by the World Economic Forum as a Technology Pioneer, and we were recognized as one of the top 10 Most Innovative Companies in Healthcare by Fast Company. Leading employers, such as BuzzFeed, Sephora, Pinterest and Chegg, trust Ginger to provide instant access to complete care for all their employees.
Investors
City Light Capital
Kaiser Permanente Ventures
Proteus Digital Health, Freenome, Vidyo, Nuvolo, Ginger, Vesta Healthcare
Kapor Capital
Via, Twilio, Thrive Market, Omada Health, Optimizely, Good Eggs, Newsela, Inkling Systems, High Fidelity, Ginger
Khosla Ventures
Instacart, DoorDash, Stripe, Palantir Technologies, Impossible Foods, View, Opendoor, Oscar Health, Affirm, Jawbone
Nimble Ventures
Figure, AppLovin, Alto Pharmacy, Apartment List, Varsity Tutors, Samba TV, BitPay, Ginger
True Ventures
Opendoor, Zymergen, Fitbit, Automattic, Personal Capital, Namely, 3D Robotics, Handshake, tray.io, Blue Bottle Coffee
WP Global Partners
Funding History
| October 2011 | $1.7M |
|---|---|
| November 2012 | $6.5M |
| December 2014 | $20.0M |
| September 2019 | $35.0M |
Management
Chief Executive Officer
Russell Glass
Chief Marketing Officer
Christine Hsu Evans
Chief Medical Officer
Omar Dawood
Chief Technology Officer
Alex Boisvert
Chief Finance Officer
Ainslie Mayberry
Chief Commercial Officer
Peter Bridges
Chief Clinical Officer
Dana Udall
Press
New York Times - Jan, 7 2020
Market Expert - Oct, 29 2019
New York Business Journal - Oct, 26 2019
TechCrunch - Sep, 4 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Ginger or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
